September 20, 2016
Combinatorial Screening of Drug Combinations Against Patient Cells: Helping Physicians Identify Personalized Cancer Therapies, T. Nguyen, Notable Labs
There is an increasing trend towards data-driven personalized approaches to drug repositioning. Notable Labs has developed an approach to screen a vast number of combinations of FDA-approved drugs against a cancer patient’s cells to identify actionable, personalized therapies that can be prescribed by their doctor. This webinar features a presentation by Transon Nguyen of Notable Labs on the combinatorial screening of drug and drug combinations to identify personalized therapies for cancer patients.
You Will Learn:
- How Notable Labs has automated their patient sample processing and combinatorial screening of drugs.
- How automation increased throughput, decreased cost and improved patient data quality.
- How informatics can plan, execute and automatically analyze data from a screen.
- How a rich dataset can expedite the implementation of cost effective treatments for cancer patients.